Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

View:
Post by lscfa on Mar 19, 2024 1:42pm

Vote NO

Shutte owns 27% of co. If he were to invest $2 million to get RP to commercialization he would own 55% of co. Does anyone really expect him to spend $2 million as a private co. or will he just shop the assets around until he finds a buyer?

 

 

Schutte

Total

Shutte %

Shs

17,401,616

65,001,560

26.8%

$2M @ $0.05/sh

40,000,000

40,000,000

100.0%

 

57,401,616

105,001,560

54.7%

 

 

 

 

 

Schutte

Total

Shutte %

Shs

17,401,616

65,001,560

26.8%

Wrts

6,744,776

11,384,559

59.2%

Options

1,155,000

4,075,000

28.3%

Convertible pref

250,000

1,089,125

23.0%

 

25,551,392

81,550,244

31.3%

Comment by lscfa on Mar 19, 2024 1:48pm
3% of asset sales to shareholders is robbery when Schutte only owns 27% of co.  Schutte can spend $100k-$200k to find a buyer and get 97% of proceeds. The 3% no. needs to be increased to at least 50%.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities